Quick Answer
BIOMARIN PHARMACEUTICAL INC reported Earnings Per Share Diluted of $1.80 per share for the year ending 2025.
- BIOMARIN PHARMACEUTICAL INC showed a decrease of -18.6% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from BIOMARIN PHARMACEUTICAL INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2008 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2008 to 2025), BIOMARIN PHARMACEUTICAL INC's Earnings Per Share Diluted has grown by 520.7%.
- Historical annual values: Fiscal year 2025: $1.80 per share | Fiscal year 2024: $2.21 per share | Fiscal year 2023: $0.87 per share | Fiscal year 2022: $0.75 per share | Fiscal year 2021: $0.35 (loss) per share | Fiscal year 2020: $4.50 per share | Fiscal year 2019: $0.13 (loss) per share | Fiscal year 2018: $0.44 (loss) per share | Fiscal year 2017: $0.67 (loss) per share | Fiscal year 2016: $3.81 (loss) per share | Fiscal year 2015: $1.07 (loss) per share | Fiscal year 2014: $0.92 (loss) per share | Fiscal year 2012: $0.95 (loss) per share | Fiscal year 2011: $0.48 (loss) per share | Fiscal year 2010: $1.73 per share | Fiscal year 2009: $0.00 per share | Fiscal year 2008: $0.29 per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: